Regulatory and clinical trial exclusion of pregnant women: economic implications for preventive interventions in low-income countries.

Hoxha M, Tashi E, Elezi B, Haxhiu H.

Open source

DOI
10.1080/14737167.2026.2737547
Published
2026-09-21
Container
Expert Rev Pharmacoecon Outcomes Res
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14737167.2026.2737547,
  title = {Regulatory and clinical trial exclusion of pregnant women: economic implications for preventive interventions in low-income countries.},
  author = {Hoxha M and  Tashi E and  Elezi B and  Haxhiu H.},
  year = {2026},
  journal = {Expert Rev Pharmacoecon Outcomes Res},
  doi = {10.1080/14737167.2026.2737547},
  url = {https://doi.org/10.1080/14737167.2026.2737547}
}

RIS

TY  - JOUR
TI  - Regulatory and clinical trial exclusion of pregnant women: economic implications for preventive interventions in low-income countries.
AU  - Hoxha M
AU  -  Tashi E
AU  -  Elezi B
AU  -  Haxhiu H.
PY  - 2026
JO  - Expert Rev Pharmacoecon Outcomes Res
DO  - 10.1080/14737167.2026.2737547
UR  - https://doi.org/10.1080/14737167.2026.2737547
ER  - 

APA

M, H., E, T., B, E., & H., H. (2026). Regulatory and clinical trial exclusion of pregnant women: economic implications for preventive interventions in low-income countries.. Expert Rev Pharmacoecon Outcomes Res. https://doi.org/10.1080/14737167.2026.2737547

Source records